Source link : https://www.newshealth.biz/health-news/fda-advisors-question-potential-role-of-novel-oral-uti-antibiotic/
An FDA advisory committee raised concerns on Monday about the potential for antibiotic resistance with and inappropriate use of a novel oral antibiotic for the treatment of uncomplicated urinary tract infections (uUTIs). During the all-day meeting, members of the Antimicrobial Drugs Advisory Committee reviewed two topics: 1) the overall risks and benefits of sulopenem etzadroxil/probenecid […]
Author : News Health
Publish date : 2024-09-10 16:18:49
Copyright for syndicated content belongs to the linked Source.
Categories